Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study.

Int J Clin Pract · 2019 · PMC6767409 · PMID 30317693

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

The treatment difference observed at Month 1 ( P < 0.001) was nominally significant because of the multiplicity step‐down procedure employed. 3.4 MSHQ bother domain Baseline MSHQ bother scores were similar between treatment groups, with the mean (SD) scores of 16.7 (3.36) and 17.1 (3.18) in the DUT‐TAM FDC therapy group and in the placebo group, respectively.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.